Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 40
2007 179
2008 281
2009 427
2010 543
2011 758
2012 1025
2013 1194
2014 1205
2015 1183
2016 1230
2017 1237
2018 1102
2019 541
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

9,229 results
Results by year
Filters applied: . Clear all
Page 1
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA and McMahon C. Diabetes Technol Ther 2019. PMID 30575414
BACKGROUND: There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. ...
BACKGROUND: There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long- …
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
McGuire DK, et al. Circulation 2019 - Clinical Trial. PMID 30586723
RESULTS: CARMELINA enrolled 6979 participants (mean age, 65.9 years; estimated glomerular filtration rate, mL/min per 1.73m(2); hemoglobin A1c, 8.0%; 62.9% men; diabetes mellitus duration, 14.8 years), including 1873 (26.8%) with a history of HF at baseline. ...
RESULTS: CARMELINA enrolled 6979 participants (mean age, 65.9 years; estimated glomerular filtration rate, mL/min per 1.73m(2); hemoglobi
Evaluation of the clinical outcomes of telehealth for managing diabetes: A PRISMA-compliant meta-analysis
Wu C, et al. Medicine (Baltimore) 2018 - Review. PMID 30412116 Free PMC article.
The change in hemoglobin A1c (HbA1c) levels was assessed as the primary outcome, and changes in blood pressure, blood lipids, body mass index (BMI), and quality of life were examined as secondary outcomes. ...
The change in hemoglobin A1c (HbA1c) levels was assessed as the primary outcome, and changes in blood pressure, blood lipids, …
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
Matthews DR, et al. Lancet 2019 - Clinical Trial. PMID 31542292
Patients aged 18-70 years were included if they had type 2 diabetes diagnosed within 2 years prior to enrolment, and centrally confirmed glycated haemoglobin A1c (HbA(1c)) of 48-58 mmol/mol (6·5-7·5%) and a body-mass index of 22-40 kg/m(2). ...
Patients aged 18-70 years were included if they had type 2 diabetes diagnosed within 2 years prior to enrolment, and centrally confirmed gly …
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial
Scirica BM, et al. Circulation 2019 - Clinical Trial. PMID 30586726
The effect of lorcaserin on weight, hemoglobin A1c, and systolic blood pressure was consistent regardless of baseline renal function. ...
The effect of lorcaserin on weight, hemoglobin A1c, and systolic blood pressure was consistent regardless of baseline renal fu …
9,229 results
Jump to page
Feedback